Table 3. Crude mortality rates and hazard ratios for CVD mortality and ASCVD mortality according to non-fasting triglyceride category.
| Baseline non-fasting triglyceride level | |||||||
| ≤59 mg/dL | 60–89 mg/dL | 90–119 mg/dL | 120–149 mg/dL | 150–179 mg/dL | 180–209 mg/dL | ≥210 mg/dL | |
| CVD death | |||||||
| Men | |||||||
| Number of participants | 254 | 587 | 595 | 398 | 295 | 213 | 511 |
| Person-years | 4,093 | 9,927 | 10,412 | 7,033 | 5,326 | 3,746 | 9,213 |
| Number of deaths | 24 | 52 | 47 | 26 | 9 | 16 | 40 |
| Crude mortality rate | 5.9 | 5.2 | 4.5 | 3.7 | 1.7 | 4.3 | 4.3 |
| Hazard ratio (95% CI) | |||||||
| Model 1 | 2.44 (1.13–5.27) | 2.16 (1.06–4.39) | 2.15 (1.05–4.39) | 1.78 (0.83–3.80) | Ref. | 2.24 (0.98–5.07) | 2.53 (1.22–5.21) |
| Model 2 | 2.68 (1.20–5.97) | 2.31 (1.12–4.79) | 2.10 (1.02–4.32) | 1.66 (0.77–3.56) | Ref. | 2.16 (0.95–4.91) | 2.50 (1.20–5.17) |
| Model 3 | 3.15 (1.38–7.20) | 2.62 (1.24–5.50) | 2.29 (1.10–4.76) | 1.76 (0.82–3.78) | Ref. | 2.19 (0.96–4.97) | 2.38 (1.14–4.94) |
| Women | |||||||
| Number of participants | 624 | 1,054 | 832 | 550 | 336 | 210 | 372 |
| Person-years | 11,810 | 19,645 | 15,080 | 10,106 | 6,102 | 3,844 | 6,846 |
| Number of deaths | 22 | 49 | 54 | 31 | 22 | 13 | 28 |
| Crude mortality rate | 1.9 | 2.5 | 3.6 | 3.1 | 3.6 | 3.4 | 4.1 |
| Hazard ratio (95% CI) | |||||||
| Model 1 | 1.67 (0.92–3.03) | 1.20 (0.72–1.99) | 1.28 (0.78–2.11) | 1.07 (0.61–1.85) | Ref. | 0.84 (0.42–1.67) | 1.18 (0.67–2.07) |
| Model 2 | 1.66 (0.89–3.08) | 1.20 (0.72–2.02) | 1.30 (0.78–2.15) | 1.08 (0.62–1.88) | Ref. | 0.76 (0.38–1.52) | 1.20 (0.68–2.10) |
| Model 3 | 1.65 (0.86–3.14) | 1.20 (0.70–2.05) | 1.29 (0.78–2.16) | 1.08 (0.62–1.88) | Ref. | 0.76 (0.38–1.52) | 1.20 (0.68–2.14) |
| Total | |||||||
| Number of participants | 878 | 1,641 | 1,427 | 948 | 631 | 423 | 883 |
| Person-years | 15,903 | 29,572 | 25,492 | 17,139 | 11,428 | 7,590 | 16,059 |
| Number of deaths | 46 | 101 | 101 | 57 | 31 | 29 | 68 |
| Crude mortality rate | 2.9 | 3.4 | 4.0 | 3.3 | 2.7 | 3.8 | 4.2 |
| Hazard ratio (95% CI) | |||||||
| Model 1 | 1.78 (1.13–2.81) | 1.44 (0.96–2.16) | 1.52 (1.01–2.28) | 1.25 (0.80–1.94) | Ref. | 1.25 (0.75–2.08) | 1.60 (1.04–2.44) |
| Model 2 | 1.88 (1.16–3.04) | 1.52 (1.00–2.30) | 1.53 (1.02–2.30) | 1.23 (0.79–1.91) | Ref. | 1.16 (0.70–1.93) | 1.62 (1.05–2.48) |
| Model 3 | 2.02 (1.23–3.32) | 1.61 (1.05–2.47) | 1.59 (1.05–2.40) | 1.25 (0.81–1.95) | Ref. | 1.16 (0.69–1.92) | 1.56 (1.01–2.41) |
| ASCVD death | |||||||
| Men | |||||||
| Number of participants | 254 | 587 | 595 | 398 | 295 | 213 | 511 |
| Person-years | 4,093 | 9,927 | 10,412 | 7,033 | 5,326 | 3,746 | 9,213 |
| Number of deaths | 14 | 26 | 23 | 12 | 5 | 7 | 18 |
| Crude mortality rate | 3.4 | 2.6 | 2.2 | 1.7 | 0.9 | 1.9 | 2.0 |
| Hazard ratio (95% CI) | |||||||
| Model 1 | 2.50 (0.90–6.98) | 1.88 (0.71–4.91) | 1.84 (0.70–4.86) | 1.44 (0.50–4.10) | Ref. | 1.71 (0.54–5.41) | 2.01 (0.74–5.43) |
| Model 2 | 3.65 (1.24–10.72) | 2.42 (0.90–6.51) | 2.03 (0.76–5.40) | 1.43 (0.50–4.09) | Ref. | 1.64 (0.51–5.19) | 1.85 (0.68–5.03) |
| Model 3 | 4.47 (1.46–13.6) | 2.83 (1.03–7.78) | 2.26 (0.84–6.09) | 1.53 (0.53–4.39) | Ref. | 1.66 (0.52–5.25) | 1.73 (0.63–4.74) |
| Women | |||||||
| Number of participants | 624 | 1,054 | 832 | 550 | 336 | 210 | 372 |
| Person-years | 11,810 | 19,645 | 15,080 | 10,106 | 6,102 | 3,844 | 6,846 |
| Number of deaths | 8 | 21 | 19 | 14 | 9 | 6 | 13 |
| Crude mortality rate | 0.7 | 1.1 | 1.3 | 1.4 | 1.5 | 1.6 | 1.9 |
| Hazard ratio (95% CI) | |||||||
| Model 1 | 1.55 (0.60–4.05) | 1.26 (0.57–2.75) | 1.09 (0.49–2.42) | 1.19 (0.51–2.76) | Ref. | 0.94 (0.33–2.64) | 1.37 (0.58–3.22) |
| Model 2 | 1.26 (0.46–3.44) | 1.10 (0.49–2.46) | 1.02 (0.45–2.29) | 1.15 (0.49–2.69) | Ref. | 0.90 (0.31–2.55) | 1.37 (0.58–3.25) |
| Model 3 | 1.28 (0.45–3.62) | 1.12 (0.49–2.58) | 1.03 (0.45–2.33) | 1.16 (0.49–2.70) | Ref. | 0.90 (0.31–2.54) | 1.35 (0.56–3.27) |
| Total | |||||||
| Number of participants | 878 | 1,641 | 1,427 | 948 | 631 | 423 | 883 |
| Person-years | 15,903 | 29,572 | 25,492 | 17,139 | 11,428 | 7,590 | 16,059 |
| Number of deaths | 22 | 47 | 42 | 26 | 14 | 13 | 31 |
| Crude mortality rate | 1.4 | 1.6 | 1.6 | 1.5 | 1.2 | 1.7 | 1.9 |
| Hazard ratio (95% CI) | |||||||
| Model 1 | 1.85 (0.94–3.63) | 1.44 (0.79–2.63) | 1.37 (0.74–2.51) | 1.24 (0.64–2.38) | Ref. | 1.21 (0.56–2.57) | 1.58 (0.84–2.98) |
| Model 2 | 2.03 (1.00–4.13) | 1.54 (0.83–2.86) | 1.41 (0.76–2.60) | 1.25 (0.65–2.41) | Ref. | 1.15 (0.54–2.46) | 1.57 (0.83–2.96) |
| Model 3 | 2.29 (1.10–4.78) | 1.70 (0.90–3.21) | 1.50 (0.80–2.79) | 1.30 (0.67–2.50) | Ref. | 1.14 (0.53–2.43) | 1.48 (0.77–2.81) |
CI, confidence interval; CVD, cardiovascular disease; ASCVD, atherosclerotic cardiovascular disease.
Model 1 was adjusted for age.
Model 2 was adjusted for variables in model 1 plus body mass index, total cholesterol, hypertension, diabetes, smoking status, and alcohol drinking status.
Model 3 was adjusted for variables in model 2 plus high-density lipoprotein cholesterol.
The model for total participants (in which sexes were combined) was also adjusted for sex.
Crude mortality rate is shown per 1,000 person-years.